These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 544029)

  • 21. Genotypic and phenotypic characterization of Trypanosoma brucei gambiense isolates from Ibba, South Sudan, an area of high melarsoprol treatment failure rate.
    Maina N; Maina KJ; Mäser P; Brun R
    Acta Trop; 2007; 104(2-3):84-90. PubMed ID: 17765860
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tryparsamide.
    Thomson KD
    Lancet; 1989 Sep; 2(8662):573. PubMed ID: 2570279
    [No Abstract]   [Full Text] [Related]  

  • 23. Trypanosoma brucei brucei: the response to Melarsoprol in mice with cerebral trypanosomiasis. An immunopathological study.
    Poltera AA; Hochmann A; Lambert PH
    Clin Exp Immunol; 1981 Nov; 46(2):363-74. PubMed ID: 7039886
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Complications observed in the treatment of trypanosomiasis in the Congo].
    Ginoux PY; Bissadidi N; Frezil JL
    Med Trop (Mars); 1984; 44(4):351-5. PubMed ID: 6521632
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Human African trypanosomiasis and normality of the cerebrospinal fluid].
    Pepin J; Milord F; Guern C
    Med Trop (Mars); 1989; 49(1):29-31. PubMed ID: 2725242
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [In vivo resistance to strains of Trypanosoma rhodesiense, Mozambique, 1985].
    Pérez Martín O; Lastre González M; Urban M; Shwalbach J
    Rev Cubana Med Trop; 1991; 43(3):189-93. PubMed ID: 9768188
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Treatment of experimental trypanosomiasis caused by Trypanosoma brucei brucei in sheep: study of the minimum active dose of melarsoprol].
    Bouteille B; Darde ML; Pestre-Alexandre M; Dumas M; Breton JC; Nicolas JA; Catanzano G; Munoz M
    Bull Soc Pathol Exot Filiales; 1988; 81(3 Pt 2):548-54. PubMed ID: 3197250
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The potentiation of arsenicals with difluoromethylornithine (DFMO): experimental studies in murine trypanosomiasis.
    Jennings FW
    Bull Soc Pathol Exot Filiales; 1988; 81(3 Pt 2):595-607. PubMed ID: 2848638
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment of Rhodesian sleeping sickness in Kenya.
    Wellde BT; Chumo DA; Reardon MJ; Abinya A; Wanyama L; Dola S; Mbwabi D; Smith DH; Siongok TA
    Ann Trop Med Parasitol; 1989 Aug; 83 Suppl 1():99-109. PubMed ID: 2619399
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ever-increasing complexities of diamidine and arsenical crossresistance in African trypanosomes.
    de Koning HP
    Trends Parasitol; 2008 Aug; 24(8):345-9. PubMed ID: 18599351
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An evaluation of prednisolone as a routine adjunct to the treatment of T. rhodesiense.
    Foulkes JR
    J Trop Med Hyg; 1975 Apr; 78(4):72-4. PubMed ID: 1152100
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical presentation and treatment outcome of sleeping sickness in Sudanese pre-school children.
    Eperon G; Schmid C; Loutan L; Chappuis F
    Acta Trop; 2007 Jan; 101(1):31-9. PubMed ID: 17207760
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The treatment of African trypanosomiasis.
    Duggan AJ
    Trop Doct; 1973 Oct; 3(4):162-4. PubMed ID: 4270411
    [No Abstract]   [Full Text] [Related]  

  • 34. [Human african trypanosomiasis: A history of its therapies and their failures].
    Ollivier G; Legros D
    Trop Med Int Health; 2001 Nov; 6(11):855-63. PubMed ID: 11703839
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hepatic mixed-function oxidase activity in mice infected with Trypanosoma brucei gambiense or treated with trypanocides.
    Shertzer HG; Hall JE; Seed JR
    Mol Biochem Parasitol; 1981 Aug; 3(4):199-204. PubMed ID: 7278880
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Experimental infection of goats with Trypanosoma brucei ssp. and effects of treatment with suramin and Mel-B.
    Wellde BT; Reardon MJ; Chumo DA; Muriithi RM; Towett S; Mwangi J
    Ann Trop Med Parasitol; 1989 Aug; 83 Suppl 1():161-9. PubMed ID: 2619390
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [East African sleeping sickness (Trypanosoma rhodesiense infection) in 2 Swiss travelers to the tropics].
    Braendli B; Dankwa E; Junghanss T
    Schweiz Med Wochenschr; 1990 Sep; 120(37):1348-52. PubMed ID: 2218457
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [A trial treatment with eflornithine of trypanosomiasis caused by Trypanosoma brucei gambiense in the Peoples Republic of the Congo].
    Eozenou P; Jannin J; Ngampo S; Carme B; Tell GP; Schechter PJ
    Med Trop (Mars); 1989; 49(2):149-54. PubMed ID: 2507863
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Human African Trypanosomiasis in a Spanish traveler returning from Tanzania.
    Gómez-Junyent J; Pinazo MJ; Castro P; Fernández S; Mas J; Chaguaceda C; Pellicé M; Gascón J; Muñoz J
    PLoS Negl Trop Dis; 2017 Mar; 11(3):e0005324. PubMed ID: 28358876
    [No Abstract]   [Full Text] [Related]  

  • 40. In vivo evaluation of reuterin and its combinations with suramin, melarsoprol, DL-alpha-difluoromethylornithine and bleomycin in mice infected with Trypanosoma brucei brucei.
    Yunmbam MK; Roberts JF
    Comp Biochem Physiol C Comp Pharmacol Toxicol; 1993 Jul; 105(3):521-4. PubMed ID: 7693393
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.